These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 35759443)
1. Role of hepatic lipid species in the progression of nonalcoholic fatty liver disease. Deng KQ; Huang X; Lei F; Zhang XJ; Zhang P; She ZG; Cai J; Ji YX; Li H Am J Physiol Cell Physiol; 2022 Aug; 323(2):C630-C639. PubMed ID: 35759443 [TBL] [Abstract][Full Text] [Related]
2. Liver lipidome signature and metabolic pathways in nonalcoholic fatty liver disease induced by a high-sugar diet. Oliveira DT; Chaves-Filho AB; Yoshinaga MY; Paiva NCN; Carneiro CM; Miyamoto S; Festuccia WT; Guerra-Sá R J Nutr Biochem; 2021 Jan; 87():108519. PubMed ID: 33017610 [TBL] [Abstract][Full Text] [Related]
3. Advances in paediatric nonalcoholic fatty liver disease: Role of lipidomics. Di Sessa A; Riccio S; Pirozzi E; Verde M; Passaro AP; Umano GR; Guarino S; Miraglia Del Giudice E; Marzuillo P World J Gastroenterol; 2021 Jul; 27(25):3815-3824. PubMed ID: 34321846 [TBL] [Abstract][Full Text] [Related]
4. The Role of Fatty Acids in Non-Alcoholic Fatty Liver Disease Progression: An Update. Hliwa A; Ramos-Molina B; Laski D; Mika A; Sledzinski T Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34199035 [TBL] [Abstract][Full Text] [Related]
5. Sex Dimorphism of Nonalcoholic Fatty Liver Disease (NAFLD) in Schiffrin M; Winkler C; Quignodon L; Naldi A; Trötzmüller M; Köfeler H; Henry H; Parini P; Desvergne B; Gilardi F Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576136 [TBL] [Abstract][Full Text] [Related]
7. Hepatic lipid droplets: A balancing act between energy storage and metabolic dysfunction in NAFLD. Mashek DG Mol Metab; 2021 Aug; 50():101115. PubMed ID: 33186758 [TBL] [Abstract][Full Text] [Related]
8. Update on lipid species and paediatric nonalcoholic fatty liver disease. Mann JP; Feldstein AE; Nobili V Curr Opin Clin Nutr Metab Care; 2017 Mar; 20(2):110-116. PubMed ID: 27906700 [TBL] [Abstract][Full Text] [Related]
9. Stable Isotope-Labeled Lipidomics to Unravel the Heterogeneous Development Lipotoxicity. Shih LM; Tang HY; Lynn KS; Huang CY; Ho HY; Cheng ML Molecules; 2018 Nov; 23(11):. PubMed ID: 30400243 [TBL] [Abstract][Full Text] [Related]
10. Lipidomic Analysis of the Protective Effects of Shenling Baizhu San on Non-Alcoholic Fatty Liver Disease in Rats. Deng Y; Pan M; Nie H; Zheng C; Tang K; Zhang Y; Yang Q Molecules; 2019 Oct; 24(21):. PubMed ID: 31683679 [TBL] [Abstract][Full Text] [Related]
17. The role of hepatic lipid composition in obesity-related metabolic disease. Willis SA; Bawden SJ; Malaikah S; Sargeant JA; Stensel DJ; Aithal GP; King JA Liver Int; 2021 Dec; 41(12):2819-2835. PubMed ID: 34547171 [TBL] [Abstract][Full Text] [Related]
18. Role of farnesoid X receptor in hepatic steatosis in nonalcoholic fatty liver disease. Xi Y; Li H Biomed Pharmacother; 2020 Jan; 121():109609. PubMed ID: 31731192 [TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease. Ipsen DH; Lykkesfeldt J; Tveden-Nyborg P Cell Mol Life Sci; 2018 Sep; 75(18):3313-3327. PubMed ID: 29936596 [TBL] [Abstract][Full Text] [Related]
20. Postprandial Plasma Lipidomics Reveal Specific Alteration of Hepatic-derived Diacylglycerols in Nonalcoholic Fatty Liver Disease. Velenosi TJ; Ben-Yakov G; Podszun MC; Hercun J; Etzion O; Yang S; Nadal C; Haynes-Williams V; Huang WA; González-Hódar L; Brychta RJ; Takahashi S; Akkaraju V; Krausz KW; Walter M; Cai H; Walter PJ; Muniyappa R; Chen KY; Gonzalez FJ; Rotman Y Gastroenterology; 2022 Jun; 162(7):1990-2003. PubMed ID: 35283114 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]